SLNO
Soleno Therapeutics, Inc.
1W: -2.9%
1M: -18.7%
3M: -35.5%
YTD: -32.5%
1Y: -36.5%
3Y: +215.2%
5Y: -73.6%
$31.84
+0.50 (+1.60%)
After Hours: $31.85 (+0.01, +0.03%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$10.5M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.7B
52W Range31.555-90.32
Volume1,250,388
Avg Volume1,560,871
Beta-3.03
Dividend—
Analyst Ratings
Company Info
CEOAnish Bhatnagar
Employees115
SectorHealthcare
IndustryBiotechnology
IPO Date2014-11-13
Websitesoleno.life
203 Redwood Shores Parkway
Redwood City, CA 94065
US
Redwood City, CA 94065
US
650 213 8444
About Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Latest News
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fulk Jennifer | A-Award | 39,200 | — | 2026-03-02 |
| Fulk Jennifer | M-Exempt | 67,660 | $39.06 | 2026-03-02 |
| Fulk Jennifer | 0 | — | 2026-03-02 | |
| Norrett Kevin | A-Award | 3,500 | — | 2026-01-21 |
| Norrett Kevin | A-Award | 4,000 | $43.65 | 2026-01-21 |